Literature DB >> 16218888

Therapeutic approaches to Chlamydia infections.

Laurence Senn1, Margaret R Hammerschlag, Gilbert Greub.   

Abstract

Chlamydia trachomatis ocular and urogenital infections represent major public health problems, whereas Chlamydophila pneumoniae is a common aetiological agent of community-acquired pneumonia. The obligate intracellular lifestyle of these established pathogens poses challenges to both their diagnosis and treatment. Tetracyclines, macrolides and quinolones remain the antimicrobials of choice for the treatment of infections due to Chlamydiaceae.

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 16218888     DOI： 10.1517/14656566.6.13.2281

Source DB:  PubMed          Journal:  Expert Opin Pharmacother        ISSN： 1465-6566            Impact factor:   3.889


  14 in total

Review 1.  Genital Chlamydia trachomatis: understanding the roles of innate and adaptive immunity in vaccine research.

Authors:  Sam Vasilevsky; Gilbert Greub; Denise Nardelli-Haefliger; David Baud
Journal:  Clin Microbiol Rev       Date:  2014-04       Impact factor: 26.132

2.  Cyto-Insectotoxin 1a from Lachesana tarabaevi Spider Venom Inhibits Chlamydia trachomatis Infection.

Authors:  Nadezhda F Polina; Marina M Shkarupeta; Anna S Popenko; Alexander A Vassilevski; Sergey A Kozlov; Eugene V Grishin; Vassili N Lazarev; Vadim M Govorun
Journal:  Probiotics Antimicrob Proteins       Date:  2012-09       Impact factor: 4.609

3.  Differences in 23S ribosomal RNA mutations between wild-type and mutant macrolide-resistant Chlamydia trachomatis isolates.

Authors:  Yong Jiang; Hui Zhu; Li-Na Yang; Yuan-Jun Liu; Shu-Ping Hou; Man-Li Qi; Quan-Zhong Liu
Journal:  Exp Ther Med       Date:  2015-06-24       Impact factor: 2.447

4.  Spider venom peptides for gene therapy of Chlamydia infection.

Authors:  Vassili N Lazarev; Nadezhda F Polina; Marina M Shkarupeta; Elena S Kostrjukova; Alexander A Vassilevski; Sergey A Kozlov; Eugene V Grishin; Vadim M Govorun
Journal:  Antimicrob Agents Chemother       Date:  2011-08-29       Impact factor: 5.191

5.  Psittacosis infection and tracheobronchomalacia in a patient undergoing thyroidectomy.

Authors:  Luke Dixon; Salvador Diaz-Cano; Klaus-Martin Schulte
Journal:  BMJ Case Rep       Date:  2011-10-28

Review 6.  Pathogenic potential of novel Chlamydiae and diagnostic approaches to infections due to these obligate intracellular bacteria.

Authors:  Daniele Corsaro; Gilbert Greub
Journal:  Clin Microbiol Rev       Date:  2006-04       Impact factor: 26.132

7.  Transformation and isolation of allelic exchange mutants of Chlamydia psittaci using recombinant DNA introduced by electroporation.

Authors:  Rachel Binet; Anthony T Maurelli
Journal:  Proc Natl Acad Sci U S A       Date:  2008-12-22       Impact factor: 11.205

8.  Impact of azithromycin resistance mutations on the virulence and fitness of Chlamydia caviae in guinea pigs.

Authors:  Rachel Binet; Anne K Bowlin; Anthony T Maurelli; Roger G Rank
Journal:  Antimicrob Agents Chemother       Date:  2010-01-11       Impact factor: 5.191

9.  Frequency of development and associated physiological cost of azithromycin resistance in Chlamydia psittaci 6BC and C. trachomatis L2.

Authors:  Rachel Binet; Anthony T Maurelli
Journal:  Antimicrob Agents Chemother       Date:  2007-10-01       Impact factor: 5.191

10.  Antibiotic susceptibility of Waddlia chondrophila in Acanthamoeba castellanii amoebae.

Authors:  Geneviève Goy; Gilbert Greub
Journal:  Antimicrob Agents Chemother       Date:  2009-03-30       Impact factor: 5.191
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.